IQVIA's revenue has grown 5.0% a year over three years, and grown 5.6% a year over five, with earnings per share compounding at 11%. Revenue growth, 3-year annual rate: +5.0% (Diagnostics & Research median +8.6%). Revenue growth, 5-year rate: +5.6%, growth has slowed since the five-year average. Earnings per share, 3-year rate: +11%, earnings outgrew revenue: margins or the share count worked for shareholders. Years of annual history on file: 15, FY2011 to FY2025, as filed.

IQVIQVIA

Healthcare

$279.21+36% 1Y

$279.21

$156.6652 weeks$279.21

Latest close: a new 52-week highOct 23, 2026what changed →

Is it growing?

Mixed

Neither accelerating nor breaking down: nothing decisive, though earnings up +17% year on year.

1 good, 2 neutral

Revenue trend+8% in a year

Trailing-twelve-month revenue vs a year earlier, from the company's own filings. Five-year pace: +6% a year.

Earnings trend+17% in a year

Trailing-twelve-month earnings per share against a year earlier. Growing faster than revenue, so margins or the share count are helping.

Margin direction−0.9 points operating

Trailing-twelve-month operating margin, 13.0% now against 13.9% a year earlier.

All from SEC EDGAR, as of Jun 30, 2026.

Against the whole market›

Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.

Revenue growth, 3 yearsmiddle of the market

Where this answer is blind. These are trailing numbers from the filings, not forecasts: an acquisition or a one-off year can flatter them, so check the quarters.

Is IQV growing?

IQVIA's revenue has grown 5.0% a year over three years, and grown 5.6% a year over five, with earnings per share compounding at 11%.

+5.0%

Revenue growth, 3-year annual rate · Diagnostics & Research median +8.6% · growing slowly · compounded from trailing twelve-month revenue

Revenue growth, 5-year rate: +5.6%
Revenue growth, 5-year rate · +5.0% over three · growth has slowed since the five-year average
Earnings per share, 3-year rate: +11%
Earnings per share, 3-year rate · revenue +5.0% · earnings outgrew revenue: margins or the share count worked for shareholders
Years of annual history on file: 15
Years of annual history on file · FY2011 to FY2025, as filed